MARKET

ATYR

ATYR

Atyr Pharma Inc
NASDAQ
3.900
+0.030
+0.78%
After Hours: 3.949 +0.049 +1.25% 19:59 02/07 EST
OPEN
3.860
PREV CLOSE
3.870
HIGH
3.975
LOW
3.780
VOLUME
748.38K
TURNOVER
--
52 WEEK HIGH
4.225
52 WEEK LOW
1.420
MARKET CAP
327.38M
P/E (TTM)
-4.1644
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATYR last week (0127-0131)?
Weekly Report · 6d ago
Weekly Report: what happened at ATYR last week (0120-0124)?
Weekly Report · 01/27 10:15
Weekly Report: what happened at ATYR last week (0113-0117)?
Weekly Report · 01/20 10:10
Weekly Report: what happened at ATYR last week (0106-0110)?
Weekly Report · 01/13 10:11
aTyr Pharma: Interesting Drug, Difficult Target Market
Seeking Alpha · 01/08 12:11
This Toast Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga · 01/06 17:29
Cantor Fitzgerald Initiates Coverage On aTyr Pharma with Overweight Rating
Benzinga · 01/06 15:43
aTyr Pharma initiated with an Overweight at Cantor Fitzgerald
TipRanks · 01/06 12:32
More
About ATYR
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause inflammation and fibrosis, or scarring, of the lungs. Efzofitimod is a tRNA synthetase derived therapy that selectively modulates activated myeloid cells through neuropilin-2 (NRP2) to resolve aberrant inflammation without immune suppression and prevent the progression of fibrosis. ATYR0101 is a fusion protein derived from a domain of aspartyl-tRNA synthetase (DARS). ATYR0101 binds directly to latent-transforming growth factor beta-binding protein 1 (LTBP1), which regulates transforming growth factor beta (TGFb). Its ATYR0750 is a fusion protein derived from a domain of alanyl-tRNA synthetase (AARS).

Webull offers aTyr Pharma Inc stock information, including NASDAQ: ATYR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATYR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATYR stock methods without spending real money on the virtual paper trading platform.